Page last updated: 2024-09-03

seryl-prolyl-lysyl-lysine and Leukemia L 1210

seryl-prolyl-lysyl-lysine has been researched along with Leukemia L 1210 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bailly, C; Bailly, F; Colson, P; Helbecque, N; Hénichart, JP; Houssier, C; Pommery, N	1

Other Studies

1 other study(ies) available for seryl-prolyl-lysyl-lysine and Leukemia L 1210

Article	Year
Relationship between DNA-binding and biological activity of anilinoacridine derivatives containing the nucleic acid-binding unit SPKK. Anti-cancer drug design, 1992, Volume: 7, Issue:1 Topics: Amino Acid Sequence; Amsacrine; Animals; Antineoplastic Agents; DNA-Binding Proteins; DNA, Neoplasm; Drug Screening Assays, Antitumor; Leukemia L1210; Mice; Molecular Sequence Data; Oligopeptides; Spectrometry, Fluorescence; Tumor Cells, Cultured	1992

Article

Year

Relationship between DNA-binding and biological activity of anilinoacridine derivatives containing the nucleic acid-binding unit SPKK.

Anti-cancer drug design, 1992, Volume: 7, Issue:1

Topics: Amino Acid Sequence; Amsacrine; Animals; Antineoplastic Agents; DNA-Binding Proteins; DNA, Neoplasm; Drug Screening Assays, Antitumor; Leukemia L1210; Mice; Molecular Sequence Data; Oligopeptides; Spectrometry, Fluorescence; Tumor Cells, Cultured

1992